CD4 and COVID-19: Circulating SARS-CoV-2 memory CD4+ T cell responses were quite robust (Fig. 4B); 42% (24/57) of COVID-19 cases at 1 month PSO had > 1.0% SARS-CoV-2-specific CD4+ T cells.